|
Treatment
Options > Who
Should Be Treated > NIH Recommendations for Hepatitis
B
Who Should Be Treated
NIH Recommendations for Hepatitis B
Almost ten years after the first drug was approved
for chronic hepatitis B, the National Institute
of Diabetes and Digestive and Kidney Diseases
of the National Institutes of Health (NIH) sponsored
the first ever 3-day conference on "The
Management of Hepatitis B: 2000", in Bethesda,
MD, September 8 - 10, 2000.
The NIH Workshop recommendations attempted to
standardize (and reform) terminologies describing
hepatitis B infected individuals and identify
general criteria regarding monitoring and treatment.
For more information,read our Summary
of NIH Recommendations.
|
HBF Drug Watch
With promising new compounds in development
for hepatitis B, there is great hope that a cure will be found in the near
future. Visit the HBF Drug
Watch for a complete list of approved hepatitis
B drugs and compounds in development, as well as our list of Hepatitis
B Clinical Trials.
Download Our Information Sheet:
 Hepatitis
B Treatment
|
